Aligos Therapeutics, Inc. SEC filings ALGS
Aligos Therapeutics, Inc. has 348 filings in SEC EDGAR's recent list, going back to Jan 16, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 6, 2026 | Nov 6, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 15, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 26, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Material agreement
|
Apr 21, 2026 | Apr 16, 2026 |
| 8-K |
Current report
Other events
|
Apr 14, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 4, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 26, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 12, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 3, 2025 | Jan 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Other events
|
Sep 5, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Aug 19, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 8, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 28, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Listing notice
|
May 31, 2024 | May 29, 2024 |
| 8-K |
Current report
Listing notice, Officer or director change
|
May 22, 2024 | May 21, 2024 |
| 8-K |
Current report
Officer or director change
|
May 15, 2024 | May 9, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 28, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Other events
|
Jan 25, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 22, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 15, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 25, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Other events
|
Oct 18, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 7, 2023 | Sep 5, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Other events
|
Aug 1, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 25, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2022 | Nov 2, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| 8-K |
Current report
Other events
|
Mar 30, 2022 | Mar 26, 2022 |
| 8-K |
Current report
Other events
|
Mar 22, 2022 | Mar 22, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Other events
|
Jan 6, 2022 | Jan 6, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 18, 2021 | Nov 16, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2021 | Jun 17, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 24, 2021 | Apr 26, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 27, 2021 | Apr 26, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 20, 2020 | Oct 20, 2020 |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ALGS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1799448
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.